The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 26th 2024
Amgen’s MariTide achieved up to 20% average weight loss at 52 weeks without hitting a plateau in individuals with obesity or overweight.
November 16th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Vegan Diet Bests Mediterranean Diet for Inducing Weight Loss, Lowering Cholesterol
February 9th 2021A randomized, cross-over trial of more than 60 overweight individuals indicates a low-fat vegan diet was more effective than a Mediterranean diet for inducing weight loss and lowering cholesterol levels.
HbA1c Variability in First Two Years After Diabetes Diagnosis Helps Predict CVD Risk
February 4th 2021An analysis of 29k patients with type 2 diabetes suggests increased HbA1c variability within the first 2 years of a diabetes diagnosis was associated with a 30-59% increase in risk of incident cardiovascular disease.
Flash CGM Reduces Diabetes-Related Events, Hospitalizations in Insulin-Treated T2D
February 3rd 2021An analysis of claims data from more than 2k patients with type 2 diabetes provides insight into the effects of initiating use of a flash CGM system on acute diabetes-related events and hospitalizations in CGM-naive patients.
Medicare Beneficiaries with Diabetes Less Likely to Receive Newer Glucose-Lowering Therapies
February 2nd 2021An analysis of more than 380k older adults with type 2 diabetes suggests Medicare Advantage Beneficiaries were less likely to initiate therapy with newer glucose-lowering agents, including GLP-1RAs, SGLT2 inhibitors, and DPP-4 inhibitors than their counterparts with commercial insurance.
Prescribing Practices Improving, But Opioids Still Prescribed at High Rate for Diabetic Neuropathy
January 28th 2021A retrospective analysis of EHR data from 3 Mayo Clinic facilities details prescribing practices for pain medications among patients with newly diagnosed diabetic peripheral neuropathy.
10-Year RCT Analysis Suggests Metabolic Surgery Bests Medical Therapy for T2D Control
January 22nd 2021Data from a 10-year follow-up analysis of a single-center RCT in Europe is offering insight into the effects of metabolic surgery versus conventional medical therapy for long-term control of type 2 diabetes.